Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0010 (-1.69%)
Sep 10, 2026, 4:10 PM AEST
Actinogen Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 16.73 | 16.5 | 9.45 | 8.46 | 16.37 |
Cash & Short-Term Investments | 16.73 | 16.5 | 9.45 | 8.46 | 16.37 |
Cash Growth | 1.40% | 74.63% | 11.71% | -48.32% | 21.65% |
Accounts Receivable | 10.82 | 5.49 | 9.02 | 3.88 | 3.64 |
Other Receivables | 0.26 | 0.31 | 0.29 | 0.24 | 0.3 |
Receivables | 11.08 | 5.8 | 9.32 | 4.12 | 3.94 |
Prepaid Expenses | 0.1 | 0.13 | 0.11 | 0.1 | 0.1 |
Total Current Assets | 27.92 | 22.43 | 18.88 | 12.69 | 20.42 |
Property, Plant & Equipment | 0.17 | 0.27 | 0.34 | 0.11 | 0.17 |
Other Intangible Assets | 1.47 | 1.78 | 2.09 | 2.41 | 2.72 |
Total Assets | 29.56 | 24.48 | 21.31 | 15.21 | 23.31 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.2 | 1.93 | 0.6 | 1.1 | 0.9 |
Accrued Expenses | 2.2 | 0.96 | 0.7 | 0.61 | 0.5 |
Short-Term Debt | 4.61 | 3.01 | - | - | - |
Current Portion of Leases | 0.08 | 0.07 | 0.06 | 0.09 | 0.08 |
Total Current Liabilities | 8.1 | 5.96 | 1.36 | 1.8 | 1.48 |
Long-Term Leases | 0.09 | 0.19 | 0.26 | - | 0.09 |
Total Liabilities | 8.18 | 6.15 | 1.62 | 1.8 | 1.57 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 145.32 | 122.28 | 106.04 | 83.65 | 81.88 |
Retained Earnings | -111.85 | -96.47 | -81.74 | -68.69 | -57.94 |
Comprehensive Income & Other | -12.09 | -7.47 | -4.61 | -1.55 | -2.2 |
Shareholders' Equity | 21.37 | 18.34 | 19.7 | 13.41 | 21.74 |
Total Liabilities & Equity | 29.56 | 24.48 | 21.31 | 15.21 | 23.31 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 4.78 | 3.26 | 0.32 | 0.09 | 0.17 |
Net Cash (Debt) | 11.95 | 13.24 | 9.13 | 8.37 | 16.21 |
Net Cash Growth | -9.73% | 44.99% | 9.06% | -48.33% | 22.57% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 3,719 | 3,177 | 2,712 | 1,816 | 1,796 |
Total Common Shares Outstanding | 3,717 | 3,177 | 2,683 | 1,816 | 1,796 |
Working Capital | 19.82 | 16.47 | 17.52 | 10.89 | 18.94 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Tangible Book Value | 19.91 | 16.55 | 17.6 | 11 | 19.02 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Machinery | 0.12 | 0.11 | 0.08 | 0.07 | 0.03 |